Lucid Diagnostics (LUCD) Revenue & Revenue Breakdown
Lucid Diagnostics Revenue Highlights
Latest Revenue (Y)
$2.43M
Latest Revenue (Q)
$976.00K
Lucid Diagnostics Revenue by Period
Lucid Diagnostics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $2.43M | 544.03% |
| 2022-12-31 | $377.00K | -24.60% |
| 2021-12-31 | $500.00K | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | - |
Lucid Diagnostics generated $2.43M in revenue during NA 2023, up 544.03% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Lucid Diagnostics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $976.00K | -2.50% |
| 2024-03-31 | $1.00M | -3.75% |
| 2023-12-31 | $1.04M | 32.82% |
| 2023-09-30 | $783.00K | 392.45% |
| 2023-06-30 | $159.00K | -64.35% |
| 2023-03-31 | $446.00K | 298.21% |
| 2022-12-31 | $112.00K | 47.37% |
| 2022-09-30 | $76.00K | 100.00% |
| 2022-06-30 | - | -100.00% |
| 2022-03-31 | $189.00K | -37.00% |
| 2021-12-31 | $300.00K | 50.00% |
| 2021-09-30 | $200.00K | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2018-12-31 | - | - |
Lucid Diagnostics generated $976.00K in revenue during Q2 2024, up -2.50% compared to the previous quarter, and up 218.83% compared to the same period a year ago.
Lucid Diagnostics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ITGR | Integer | $1.60B | $753.01M |
| LIVN | LivaNova | $1.15B | $318.60M |
| NARI | Inari Medical | $493.63M | $145.82M |
| FNA | Paragon 28 | $216.39M | $61.02M |
| KIDS | OrthoPediatrics | $148.73M | $52.80M |
| SRDX | Surmodics | $132.58M | $30.34M |
| LUNG | Pulmonx | $68.67M | $20.78M |
| IRMD | IRadimed | $65.56M | $17.93M |
| NPCE | NeuroPace | $65.42M | $18.12M |
| CVRX | CVRx | $39.30M | $11.81M |
| OSA | ProSomnus | $27.65M | $7.46M |
| CLPT | ClearPoint Neuro | $23.95M | $7.86M |
| LUCD | Lucid Diagnostics | $2.43M | $976.00K |
| XAIR | Beyond Air | $1.16M | $683.00K |
| OFIX | Orthofix Medical | $100.00K | $198.62M |
LUCD Revenue FAQ
What is Lucid Diagnostics’s yearly revenue?
Lucid Diagnostics's yearly revenue for 2023 was $2.43M, representing an increase of 544.03% compared to 2022. The company's yearly revenue for 2022 was $377K, representing a decrease of -24.60% compared to 2021. LUCD's yearly revenue for 2021 was $500K, representing an increase of 100.00% compared to 2020.
What is Lucid Diagnostics’s quarterly revenue?
Lucid Diagnostics's quarterly revenue for Q2 2024 was $976K, a -2.50% decrease from the previous quarter (Q1 2024), and a 513.84% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $1M, a -3.75% decrease from the previous quarter (Q4 2023), and a 124.44% increase year-over-year (Q1 2023). LUCD's quarterly revenue for Q4 2023 was $1.04M, a 32.82% increase from the previous quarter (Q3 2023), and a 828.57% increase year-over-year (Q4 2022).
What is Lucid Diagnostics’s revenue growth rate?
Lucid Diagnostics's revenue growth rate for the last 3 years (2021-2023) was 385.60%, and for the last 5 years (2019-2023) was 0%.